Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 350

1.

A profibrotic role for thymic stromal lymphopoietin in systemic sclerosis.

Usategui A, Criado G, Izquierdo E, Del Rey MJ, Carreira PE, Ortiz P, Leonard WJ, Pablos JL.

Ann Rheum Dis. 2013 Dec;72(12):2018-23. doi: 10.1136/annrheumdis-2012-202279.

PMID:
23413283
2.
3.

Topical vitamin D analogue calcipotriol reduces skin fibrosis in experimental scleroderma.

Usategui A, Criado G, Del Rey MJ, Faré R, Pablos JL.

Arch Dermatol Res. 2014 Oct;306(8):757-61. doi: 10.1007/s00403-014-1466-6.

PMID:
24788893
4.

Amelioration of tissue fibrosis by toll-like receptor 4 knockout in murine models of systemic sclerosis.

Takahashi T, Asano Y, Ichimura Y, Toyama T, Taniguchi T, Noda S, Akamata K, Tada Y, Sugaya M, Kadono T, Sato S.

Arthritis Rheumatol. 2015 Jan;67(1):254-65. doi: 10.1002/art.38901.

5.

Treatment with rapamycin prevents fibrosis in tight-skin and bleomycin-induced mouse models of systemic sclerosis.

Yoshizaki A, Yanaba K, Yoshizaki A, Iwata Y, Komura K, Ogawa F, Takenaka M, Shimizu K, Asano Y, Hasegawa M, Fujimoto M, Sato S.

Arthritis Rheum. 2010 Aug;62(8):2476-87. doi: 10.1002/art.27498.

6.

Th17 cells and IL-17 promote the skin and lung inflammation and fibrosis process in a bleomycin-induced murine model of systemic sclerosis.

Lei L, Zhao C, Qin F, He ZY, Wang X, Zhong XN.

Clin Exp Rheumatol. 2016 Sep-Oct;34 Suppl 100(5):14-22.

PMID:
26750756
7.

Activation of pregnane X receptor inhibits experimental dermal fibrosis.

Beyer C, Skapenko A, Distler A, Dees C, Reichert H, Munoz L, Leipe J, Schulze-Koops H, Distler O, Schett G, Distler JH.

Ann Rheum Dis. 2013 Apr;72(4):621-5. doi: 10.1136/annrheumdis-2012-202476.

PMID:
23291432
8.

The nuclear receptor constitutive androstane receptor/NR1I3 enhances the profibrotic effects of transforming growth factor β and contributes to the development of experimental dermal fibrosis.

Avouac J, Palumbo-Zerr K, Ruzehaji N, Tomcik M, Zerr P, Dees C, Distler A, Beyer C, Schneider H, Distler O, Schett G, Allanore Y, Distler JH.

Arthritis Rheumatol. 2014 Nov;66(11):3140-50. doi: 10.1002/art.38819.

9.

Toll-like receptor 3 upregulation by type I interferon in healthy and scleroderma dermal fibroblasts.

Agarwal SK, Wu M, Livingston CK, Parks DH, Mayes MD, Arnett FC, Tan FK.

Arthritis Res Ther. 2011 Jan 11;13(1):R3. doi: 10.1186/ar3221.

10.

Antifibrotic effects of crocetin in scleroderma fibroblasts and in bleomycin-induced sclerotic mice.

Song Y, Zhu L, Li M.

Clinics (Sao Paulo). 2013 Oct;68(10):1350-7. doi: 10.6061/clinics/2013(10)10.

11.

A convenient method for producing the bleomycin-induced mouse model of scleroderma by weekly injections using a methylcellulose gel.

Jun JB, Kim JK, Na YI, Jang SM, Paik SS, Kim YH.

Rheumatol Int. 2012 May;32(5):1443-7. doi: 10.1007/s00296-011-1884-0.

PMID:
21448642
12.

Critical role of the adhesion receptor DNAX accessory molecule-1 (DNAM-1) in the development of inflammation-driven dermal fibrosis in a mouse model of systemic sclerosis.

Avouac J, Elhai M, Tomcik M, Ruiz B, Friese M, Piedavent M, Colonna M, Bernhardt G, Kahan A, Chiocchia G, Distler JH, Allanore Y.

Ann Rheum Dis. 2013 Jun;72(6):1089-98. doi: 10.1136/annrheumdis-2012-201759.

PMID:
23161903
13.

Heat shock protein 90 (Hsp90) inhibition targets canonical TGF-β signalling to prevent fibrosis.

Tomcik M, Zerr P, Pitkowski J, Palumbo-Zerr K, Avouac J, Distler O, Becvar R, Senolt L, Schett G, Distler JH.

Ann Rheum Dis. 2014 Jun;73(6):1215-22. doi: 10.1136/annrheumdis-2012-203095.

PMID:
23661493
14.

2-Methoxyestradiol inhibits bleomycin-induced systemic sclerosis through suppression of fibroblast activation.

Zhu L, Song Y, Li M.

J Dermatol Sci. 2015 Jan;77(1):63-70. doi: 10.1016/j.jdermsci.2014.10.007.

PMID:
25465161
15.

Tumor necrosis factor superfamily 14 (LIGHT) controls thymic stromal lymphopoietin to drive pulmonary fibrosis.

Herro R, Da Silva Antunes R, Aguilera AR, Tamada K, Croft M.

J Allergy Clin Immunol. 2015 Sep;136(3):757-68. doi: 10.1016/j.jaci.2014.12.1936.

16.

Alpha2-antiplasmin regulates the development of dermal fibrosis in mice by prostaglandin F(2α) synthesis through adipose triglyceride lipase/calcium-independent phospholipase A(2).

Kanno Y, Kawashita E, Kokado A, Okada K, Ueshima S, Matsuo O, Matsuno H.

Arthritis Rheum. 2013 Feb;65(2):492-502. doi: 10.1002/art.37767. Erratum in: Arthritis Rheum. 2014 Jun;66(6):1671.

17.

The specific free radical scavenger edaravone suppresses fibrosis in the bleomycin-induced and tight skin mouse models of systemic sclerosis.

Yoshizaki A, Yanaba K, Ogawa A, Iwata Y, Ogawa F, Takenaka M, Shimizu K, Asano Y, Kadono T, Sato S.

Arthritis Rheum. 2011 Oct;63(10):3086-97. doi: 10.1002/art.30470.

18.

Identification of cadherin 11 as a mediator of dermal fibrosis and possible role in systemic sclerosis.

Wu M, Pedroza M, Lafyatis R, George AT, Mayes MD, Assassi S, Tan FK, Brenner MB, Agarwal SK.

Arthritis Rheumatol. 2014 Apr;66(4):1010-21. doi: 10.1002/art.38275.

19.

CD109 overexpression ameliorates skin fibrosis in a mouse model of bleomycin-induced scleroderma.

Vorstenbosch J, Al-Ajmi H, Winocour S, Trzeciak A, Lessard L, Philip A.

Arthritis Rheum. 2013 May;65(5):1378-83. doi: 10.1002/art.37907.

20.

MicroRNA-29, a key regulator of collagen expression in systemic sclerosis.

Maurer B, Stanczyk J, Jüngel A, Akhmetshina A, Trenkmann M, Brock M, Kowal-Bielecka O, Gay RE, Michel BA, Distler JH, Gay S, Distler O.

Arthritis Rheum. 2010 Jun;62(6):1733-43. doi: 10.1002/art.27443.

Supplemental Content

Support Center